home
stocks
AstraZeneca Pharma Ind

AstraZeneca Pharma Ind Share Price

Q: What is the AstraZeneca Pharma Ind share price today?

AstraZeneca Pharma Ind share price is Rs. 5,284.80 today.

Q: What is today’s high & low stock price of AstraZeneca Pharma Ind?

AstraZeneca Pharma Ind stock price high: Rs. 5,324.15 and low: Rs. 5,245.00

Q: What is the market capital of AstraZeneca Pharma Ind shares today?

AstraZeneca Pharma Ind has a market capitalization of Rs. 13,113.63 Crores.

Q: What is the AstraZeneca Pharma Ind stock price high and low in the last 52 weeks on the NSE?

52 Week Stock High Price is Rs. 7,220.95 and Low Price is Rs. 3,098.00

Q: What is the AstraZeneca Pharma Ind Stock Symbol?

The AstraZeneca Pharma Ind Stock symbol is ASTRAZEN.

Q: Can I buy AstraZeneca Pharma Ind shares on Holidays?

<div class="text-sm text-gray-accent3">No, shares of AstraZeneca Pharma Ind or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell AstraZeneca Pharma Ind shares on days when the stock exchanges are open for trading. It's important to check the <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/nse-holidays-2024/">NSE</a> & <a class="text-primary-base" target="_blank" href="https://upstox.com/stocks-market/bse-holidays-2024/">BSE</a> holidays calendar, before placing any trades to avoid any inconvenience.</div>

Q: Can I do stock trading on my phone?

<div class="text-sm text-gray-accent3">Yes, Upstox trading app allows you to trade easily once KYC documents are verified online. This app is available for both iOS and Android devices. For the Android app, <a class="text-primary-base" target="_blank" href="https://play.google.com/store/apps/details?id=in.upstox.app&pli=1">click here</a>, and for the iOS app, <a class="text-primary-base" target="_blank" href="https://apps.apple.com/in/app/upstox-stocks-ipo-mf/id1584953620">click here</a>.</div>

ASTRAZEN

₹5,284.80+₹39.35 (0.75%) Past YearLast updated on 24 Apr, 2024 | 03:50 PM IST

₹5,245.00₹5,324.15

News
Company overview
Fundamentals
Events
More

What’s in news?

Moneycontrol • 2w

AstraZeneca, Daiichi drug gets broad tumor approval in US

Moneycontrol • 4w

Gainers and Losers: 10 stocks that moved the most on March 27

Moneycontrol • 4w

AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment

ZEEBIZ • 1mo

AstraZeneca to buy Fusion Pharma for $2 billion in cash

Moneycontrol • 1mo

AstraZeneca Pharma India, Mankind Pharma ink a pact!

ET • 2mo

AstraZeneca targets 2024 growth but mixed views hit shares

ET • 3mo

25 stocks hit fresh 52-week high in BSE Healthcare index

Moneycontrol • 4mo

Gainers and Losers: stocks that moved the most on December 21

Moneycontrol • 4mo

AstraZeneca Pharma to launch breast cancer drug, shares jump 6%

Moneycontrol • 4mo

AstraZeneca, AI biologics firm Absci tie up on cancer drug

Company overview

About

Market cap

₹13,114 Cr

Open

₹5,324.15

Close

₹5,245.45

Circuit range

₹6,294.50 - ₹4,196.40

Day range

₹5,245.00 - ₹5,324.15

Year range

₹3,098.00 - ₹7,220.95

Volume

2,128

Avg. traded

₹5,288.30

Revenue (12m)

₹1,197 Cr

AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

52 week high

₹7,220.95

52 week low

₹3,098.00

P/E ratio

94.15 P/B ratio

19.58 ROE

18.13%

ROCE

24.49%

Dividend yield

0.3%

Debt/Equity ratio

EPS

39.72

Learn more

Featured in

Pharmaceuticals

Investment checklist: (5/6)

Equity returns

Dividend returns

Safety factor

Growth factor

Debt vs Equity

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

Profitability
Operational
Valuation

Operating profit margin

18.98%

Net profit margin

9.85%

ROE

18.13%

ROA

9.37%

ROCE

24.49%

Learn more

AstraZeneca Pharma Ind Shareholder returns

1 day

+0.03%

1 week

+0.88%

1 month

+2.24%

3 months

-17.06%

1 year

+65.85%

3 years

+23.88%

5 years

+136.10%

Revenue statement

All values are in ₹ Crores (Cr)

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)

No data available at the moment

AstraZeneca Pharma Ind Share Price history

Day	Open	Close	Day’s change
Tue, Apr 23 2024	₹5,239.90	₹5,245.45	+0.11%
Mon, Apr 22 2024	₹5,252.95	₹5,243.90	-0.17%
Fri, Apr 19 2024	₹5,202.55	₹5,189.70	-0.25%
Thu, Apr 18 2024	₹5,285.10	₹5,224.15	-1.17%
Tue, Apr 16 2024	₹5,198.00	₹5,285.10	+1.65%
Mon, Apr 15 2024	₹5,253.00	₹5,199.95	-1.02%
Fri, Apr 12 2024	₹5,420.80	₹5,307.70	-2.13%
Wed, Apr 10 2024	₹5,357.25	₹5,398.50	+0.76%